Washington 2000/04/19 - The American Cancer Society, the nation’s
leading voluntary health organization, today expressed skepticism over R.J.
Reynolds Tobacco Company’s reintroduction of a "safer" cigarette, Eclipse, and
called for meaningful federal oversight to substantiate such claims.
"The tobacco industry’s long history of deception should give the American
public pause," said John R. Seffrin, Ph.D., Chief Executive Officer of the
American Cancer Society. "Because there is no independent scientific oversight
or authority over tobacco products, the industry feels free to make
unsubstantiated claims about the safety of its products. But the bottom line is
that the cancer risks associated with tobacco use are still undeniably
great."
According to news reports, RJR will make the claim that smoking Eclipse-brand
cigarettes "may reduce the risk of smoking-associated cancers" and lower the
risk of lung disease.
"RJR’s health claims, which have not been substantiated by any federal or
independent body, only serve to confuse the public about the dangers of
tobacco," added Seffrin. "For this reason, we are calling for Congress to act
now and provide the FDA with the type of oversight that could verify or refute
these types of assertions. Only through meaningful FDA regulation can we prevent
Big Tobacco from making unverifiable claims about their deadly products."
Tobacco use is the number one preventable cause of death in America, killing
nearly 430,000 people each year. Thirty percent of all cancer cases are
attributable to tobacco-use. More than $50 billion is spent in health care costs
each year to treat smokers suffering from cardiovascular disease, cancer and
lung disease, and other related ailments.
The American Cancer Society is the nationwide community-based voluntary
health organization dedicated to eliminating cancer as a major health problem by
preventing cancer, saving lives and diminishing suffering from cancer, through
research, education, advocacy and service.
Unice B. Lieberman
Director, Advocacy Communications
American Cancer Society
202-661-5710
Unice.Lieberman@cancer.org
|